Delegation of Authority, 40705 [2016-14802]

Download as PDF 40705 Federal Register / Vol. 81, No. 120 / Wednesday, June 22, 2016 / Notices Handbook no later than 30 days after the end of each 12-month budget period. Likely Respondents: Fifty State Offices of Rural Health. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this Information Collection Request are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours Technical Assistance Report ............................................... 50 1 50 12.5 625 Total .............................................................................. 50 ........................ 50 ........................ 625 HRSA specifically requests comments on: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Jason E. Bennett, Director, Division of the Executive Secretariat. [FR Doc. 2016–14658 Filed 6–21–16; 8:45 am] BILLING CODE 4165–15–P With respect to the HHS Acquisition Regulations only, the Inspector General will be considered an OPDIV head for the purposes of the December 21, 1994, delegation from the Secretary to the OPDIV heads to approve and issue noncontroversial regulations. Exercise of these authorities shall be in accordance with established policies, procedures, guidelines, and regulations as prescribed by the Secretary. This delegation is effective on the date of signature. Dated: June 16, 2016. Sylvia M. Burwell, Secretary. [FR Doc. 2016–14802 Filed 6–21–16; 8:45 am] BILLING CODE 4152–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary mstockstill on DSK3G9T082PROD with NOTICES Delegation of Authority National Institutes of Health Notice is hereby given that I have delegated to the Office of the Inspector General (OIG) the acquisition administrative authorities of the Secretary, except the authority to approve and issue HHS Acquisition Regulations. In addition, by the authority vested in the Secretary by section 1702 of Title 41 pf the United States Code (Pub. L. 111– 350, § 3, Jan. 4, 2011), I have designated; (a) the Inspector General as the OIG Chief Acquisition Officer; and (b) the Principal Deputy Inspector General as OIG Senior Procurement Executive. I also delegate to the Inspector General the authority under section 1705 of Title 41 of the United States Code (Pub. L. 111–350, § 3, Jan. 4, 2011) to designate a competition advocate for OIG. The authorities may be redelegated to the extent permitted by law. VerDate Sep<11>2014 20:02 Jun 21, 2016 Jkt 238001 Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–14– PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 315: Developing and Testing Interventions for Health-Enhancing Physical Activity. Date: July 1, 2016. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Weijia Ni, Ph.D., Chief/ Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD 20892, 301–594– 3292, niw@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Psycho/Neuropathology, Lifespan Development, and STEM Education Overflow. Date: July 6, 2016. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: John H. Newman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 20892, (301) 435– 0628, newmanjh@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Developmental Risk Prevention, Aging and Social Behavior. Date: July 7, 2016. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Weijia Ni, Ph.D., Chief/ Scientific Review Officer, Center for E:\FR\FM\22JNN1.SGM 22JNN1

Agencies

[Federal Register Volume 81, Number 120 (Wednesday, June 22, 2016)]
[Notices]
[Page 40705]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14802]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Delegation of Authority

    Notice is hereby given that I have delegated to the Office of the 
Inspector General (OIG) the acquisition administrative authorities of 
the Secretary, except the authority to approve and issue HHS 
Acquisition Regulations.
    In addition, by the authority vested in the Secretary by section 
1702 of Title 41 pf the United States Code (Pub. L. 111-350, Sec.  3, 
Jan. 4, 2011), I have designated; (a) the Inspector General as the OIG 
Chief Acquisition Officer; and (b) the Principal Deputy Inspector 
General as OIG Senior Procurement Executive.
    I also delegate to the Inspector General the authority under 
section 1705 of Title 41 of the United States Code (Pub. L. 111-350, 
Sec.  3, Jan. 4, 2011) to designate a competition advocate for OIG. The 
authorities may be re-delegated to the extent permitted by law.
    With respect to the HHS Acquisition Regulations only, the Inspector 
General will be considered an OPDIV head for the purposes of the 
December 21, 1994, delegation from the Secretary to the OPDIV heads to 
approve and issue noncontroversial regulations.
    Exercise of these authorities shall be in accordance with 
established policies, procedures, guidelines, and regulations as 
prescribed by the Secretary.
    This delegation is effective on the date of signature.

    Dated: June 16, 2016.
Sylvia M. Burwell,
Secretary.
[FR Doc. 2016-14802 Filed 6-21-16; 8:45 am]
 BILLING CODE 4152-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.